Apple has announced that its smartwatch's hypertension detection system has received approval from the U.S. Food and Drug Administration (FDA) and will be launched next week in over 150 countries and regions. This feature utilizes data from the Apple Watch's optical heart rate sensor to analyze the user's vascular response to heartbeats over a 30-day period, providing hypertension detection services.